Bridion 200 MG/2 ML vial 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F47LM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,350
Award facts
- Contract value 100% obligated
- $15,350.01 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $15,350.01 to AmerisourceBergen Drug Corp for the supply of Bridion 200 mg/2 mL vials on January 16, 2026, with an ultimate completion date of January 20, 2026. This firm fixed-price contract represents a non-competitive set-aside award and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. Bridion (sugammadex) is a neuromuscular blocking agent reversal medication used in surgical and anesthesia settings, reflecting the Defense Logistics Agency's role in supplying critical pharmaceuticals to military healthcare systems.
This delivery order was issued under AmerisourceBergen Drug Corp's parent company, Cencora, Inc., which holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2031. This comprehensive pharmaceutical IDC serves as the primary vehicle for delivering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs globally. The contract structure enables efficient fulfillment of medical supply needs across the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, with AmerisourceBergen/Cencora operating as a critical pharmaceutical distributor within the military medical supply chain.
Quick answers
Who was awarded contract SPE2DR26F47LM?
SPE2DR26F47LM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 16, 2026.
How much is contract SPE2DR26F47LM worth?
The government has obligated $15,350 on SPE2DR26F47LM.
Is contract SPE2DR26F47LM an order under another contract?
Yes. SPE2DR26F47LM is a delivery order under SPE2DR25D2101, an indefinite delivery contract.
Was contract SPE2DR26F47LM competed?
The extent of competition for SPE2DR26F47LM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award